Patent · US Active

Bispecific immunomodulatory antibodies that bind costimulatory and checkpoint receptors

US10793632B2 · kind B2 · utility

14Cited by
119References
5Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 30, 2017
Grant dateOct 6, 2020
Priority date—
Expiry dateAug 30, 2037

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/94
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention is directed to bispecific, heterodimeric immunomodulatory antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.